GH Schernthaner, G Schernthaner - Scandinavian Journal of Clinical & Laboratory …, 2005 - informahealthcare.com Prospective studies of prediabetic subjects have shown that obesity and its
duration are major risk factors for type 2 diabetes. Longitudinal studies are
consistent with an etiologic role of subclinical inflammation in the ... Cited by 15 - Related articles - BL Direct - All 7 versions
J Yin, H Xing, J Ye - Metabolism: clinical and experimental, 2008 - pubmedcentral.nih.gov Berberine has been shown to regulate glucose and lipid metabolism in vitro and
in vivo. This pilot study was to determine the efficacy and safety of berberine
in the treatment of type 2 diabetic patients. In study A, 36 adults with ... Cited by 14 - Related articles - All 12 versions
- ►eje.org SS Lund, L Tarnow, M Frandsen, UM Smidt, O … - European Journal of Endocrinology, 2008 - eje.org Objective: Non-obese patients with type 2 diabetes (T2DM) are characterized by
predominant defective insulin secretion. However, in non-obese T2DM patients,
metformin, targeting insulin resistance, is non-inferior to the prandial ... Cited by 12 - Related articles - BL Direct - All 11 versions
A Pfützner, T Forst - Expert Opin. Pharmacother., 2006 - Informa Pharma Science Pioglitazone is an antidiabetic drug known to decrease peripheral, hepatic and
vascular insulin resistance by the stimulation of PPARγ. In clinical trials,
pioglitazone as monotherapy or in combination with other oral antidiabetic ... Cited by 11 - Related articles - BL Direct - All 5 versions
L Monnier, C Colette, JF Thuan, H Lapinski - European journal of clinical investigation, 2006 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 12 - Related articles - BL Direct - All 4 versions
A Ceriello, TUK Ltd - Diabetes/Metabolism Reviews - interscience.wiley.com In the last few years, there has been increasing focus on the impact of
interventions on cardiovascular outcomes in patients with type 2 diabetes.
Insulin resistance and hyperglycaemia often co-exist with a cluster of risk ... Cited by 6 - Related articles - BL Direct - All 3 versions
M Hanefeld - International Journal of Clinical Practice, 2007 - pubmedcentral.nih.gov Type 2 diabetes is characterised by a gradual decline in glycaemic control and
progression from oral glucose-lowering monotherapy to combination therapy and
exogenous insulin therapy. Functional decline of the insulin-secreting ... Cited by 4 - Related articles - BL Direct - All 8 versions
Y Moritoh, K Takeuchi, T Asakawa, O Kataoka … - British Journal of Pharmacology, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 3 - Related articles - All 2 versions
